{"cdcTestId":"2022-0031","testcaseName":"Patient is 12 years of age and has been administered Moderna\u0027s (CVX 221) Covid-19 vaccine for the first and second dose","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-09-07T00:00:00","patient":{"dob":"2010-07-20T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-07-10T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-07T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-10-02T00:00:00","recommendedDate":"2022-10-02T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-07-10T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-07T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"221","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-09-29T08:14:42.706","generalDescription":"This test case describes when a patient that is 12 years is administered Moderna (CVX 221) Covid-19 vaccine as the first and second dose that the doses are considered to be valid. Another dose should be forecast.","changedInVersion":"4.27","reasonForChange":"v4.27 Updated Forecast Dates to align with the current Interim Clinical Considerations (09/2/2022) for a new bivalent mRNA booster 8 weeks after completion of a monovalent primary series; it replaces all prior booster recommendations for this age group."}